| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 28.62B | 24.86B | 22.09B | 21.07B | 21.19B |
| Gross Profit | 7.30B | 6.16B | 5.35B | 4.47B | 4.57B |
| EBITDA | 3.70B | 3.15B | 2.72B | 2.28B | 2.29B |
| Net Income | 1.93B | 1.38B | 936.47M | 682.48M | 638.17M |
Balance Sheet | |||||
| Total Assets | 23.49B | 22.01B | 20.82B | 20.12B | 18.92B |
| Cash, Cash Equivalents and Short-Term Investments | 6.37B | 5.69B | 6.59B | 5.88B | 5.40B |
| Total Debt | 1.32B | 1.65B | 2.05B | 2.06B | 1.38B |
| Total Liabilities | 7.47B | 7.35B | 6.97B | 6.68B | 6.01B |
| Stockholders Equity | 16.01B | 14.66B | 13.85B | 13.44B | 12.91B |
Cash Flow | |||||
| Free Cash Flow | 1.87B | 386.01M | 1.70B | 1.09B | 1.58B |
| Operating Cash Flow | 2.25B | 742.04M | 2.51B | 1.71B | 2.12B |
| Investing Cash Flow | -360.90M | -608.45M | -595.27M | -475.22M | -518.83M |
| Financing Cash Flow | -1.15B | -1.03B | -1.20B | -756.48M | -744.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥29.39B | 10.67 | ― | 2.93% | 12.16% | 18.97% | |
76 Outperform | ¥21.74B | 13.65 | ― | 2.53% | 13.31% | 28.58% | |
71 Outperform | ¥18.10B | 30.80 | ― | 3.14% | -3.85% | -17.22% | |
71 Outperform | ¥30.09B | 29.25 | ― | 0.82% | 6.86% | 37.45% | |
69 Neutral | ¥17.61B | 9.72 | ― | 2.40% | 15.12% | 40.67% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |